JPS636079B2 - - Google Patents
Info
- Publication number
- JPS636079B2 JPS636079B2 JP7454979A JP7454979A JPS636079B2 JP S636079 B2 JPS636079 B2 JP S636079B2 JP 7454979 A JP7454979 A JP 7454979A JP 7454979 A JP7454979 A JP 7454979A JP S636079 B2 JPS636079 B2 JP S636079B2
- Authority
- JP
- Japan
- Prior art keywords
- phosphorylcholine
- general formula
- choline
- reaction
- cdp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229950004354 phosphorylcholine Drugs 0.000 claims description 31
- RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 claims description 30
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 10
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 10
- 229960001284 citicoline Drugs 0.000 claims description 8
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 8
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 3
- 235000019743 Choline chloride Nutrition 0.000 claims description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 3
- 229960003178 choline chloride Drugs 0.000 claims description 3
- 125000005265 dialkylamine group Chemical group 0.000 claims description 2
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims 5
- 238000006243 chemical reaction Methods 0.000 description 25
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- -1 monosubstituted amides Chemical class 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000013078 crystal Substances 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004816 paper chromatography Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LOUZURPQCYZSJH-UHFFFAOYSA-N 1-chloro-2-dichlorophosphorylethane Chemical compound ClCCP(Cl)(Cl)=O LOUZURPQCYZSJH-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical class CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 2
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical class OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- ZWIADYZPOWUWEW-XVFCMESISA-N CDP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-XVFCMESISA-N 0.000 description 1
- ZWIADYZPOWUWEW-UHFFFAOYSA-N Cytidine 5'-diphosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- JXYZHMPRERWTPM-UHFFFAOYSA-N hydron;morpholine;chloride Chemical compound Cl.C1COCCN1 JXYZHMPRERWTPM-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Description
ãçºæã®è©³çްãªèª¬æã
æ¬çºæã¯ã·ããžã³ãžãªã³é
žã³ãªã³ïŒä»¥äžã
CDPâã³ãªã³ãšç¥ããïŒãå·¥æ¥çã«è£œé ããæ¹æ³
ã«é¢ãããDetailed Description of the Invention The present invention provides choline cytidine diphosphate (hereinafter referred to as
Abbreviated as CDP-choline. ).
CDPâã³ãªã³ã¯è³å€å·æã®æèé害ããã³æ©
èœé害ã®å埩ã«çšããããŠããéèŠãªå»è¬ã§ã
ãããã®è£œé æ¹æ³ãåçš®ç¥ãããŠãããäŸãã°ã
(1)ã·ããžã³â5â²âãªã³é
žïŒä»¥äžã5â²âCMPãšç¥
ããïŒãšãã¹ããªã«ã³ãªã³ãçž®åããããæ¹æ³ã
ïŒç¹å
¬æ35â13024ãç¹å
¬æ46â37594ãç¹å
¾46
â18990ãçãïŒ(2)5â²âCMPã®æŽ»æ§åèªå°äœãšã
ã¹ããªã«ã³ãªã³ãåå¿ãããæ¹æ³ãïŒç¹å
¬æ42â
1384ãç¹å
¬æ46â2101ãçãïŒ(3)ãã¹ããªã«ã³ãª
ã³ã®æŽ»æ§åèªå°äœãš5â²âCMPãåå¿ãããæ¹æ³ã
ïŒç¹å
¬æ45â4747ãç¹å
¬æ52â16115ãçãïŒ(4)ã·
ããžã³â5â²âãžãªã³é
žãšã¿ããŒã«ã¢ãã³ãçµç±ã
ãæ¹æ³ãïŒç¹å
¬æ39â6541ãç¹éæ47â11476ã
çãïŒçãç¥ãããŠãããããããªãããããã®
æ¹æ³ã¯ãé«äŸ¡ãªè©Šè¬ã®äœ¿çšãåå¿ãæäœãåçã®
ããããããŸãã¯ãã®äºã€ä»¥äžã®ç¹ã§äžå©ãªç¹ã
ããå·¥æ¥çã«å¿
ãããæå©ãªæ¹æ³ã§ã¯ãªãã CDP-choline is an important drug used for recovery from impaired consciousness and functional impairment caused by brain trauma, and various methods for its production are known. for example,
(1) A method of condensing cytidine-5'-phosphate (hereinafter abbreviated as 5'-CMP) and phosphorylcholine.
(Tokuko Sho 35-13024, Sho 46-37594, Sho 46
â18990, etc. )(2) A method of reacting an activated derivative of 5â²-CMP with phosphorylcholine. (Tokuko Showa 42-
1384, Special Publication Showa 46-2101, etc. )(3) A method of reacting an activated derivative of phosphorylcholine with 5'-CMP.
(Special Publication No. 45-4747, No. 52-16115, etc.) (4) Method via cytidine-5'-diphosphate ethanolamine. (Special Publication No. 39-6541, No. 47-11476,
etc. ) etc. are known. However, these methods have disadvantages in the use of expensive reagents, reaction, operation, yield, or both, and are not necessarily industrially advantageous.
æ¬çºæè
ãã¯ãããåŸæ¥æ³ã®æ¬ ç¹ããªããå®äŸ¡
ã§ãåå¿ãæäœãç°¡åã§å·¥æ¥çã«æå©ãªCDPâ
ã³ãªã³ã®è£œé æ³ã確ç«ããç®çã§éæç ç©¶ããçµ
æãåæ±ãæããå®äŸ¡ã§ãããåå¿æ§ã«è±ãæ°èŠ
ãªäžè¬åŒãã
ïŒåŒäžïŒ®ïŒïŒ²ïŒ2ã¯ã¢ã«ããªãåºããŸãã¯äœçŽãžã¢
ã«ãã«ã¢ããåºã瀺ããïŒã§è¡šããããäžéäœïŒ
ãã¹ããªã«ã³ãªã³ãžã¢ãããŒãé¡ãèŠãåºããã
åŸæ¥ãã¹ããªã«ã³ãªã³ã®ã¢ããé¡ã«ã€ããŠã¯ã¢ã
眮æã¢ããé¡ããç¥ãããŠããªãã€ãããïŒäŸã
ã°ç¹å
¬æ45â27561ãç¹éæ47â38929ã西ç¬ç¹èš±
å
¬é2359245ïŒããã¯ãã¹ããªã«ã³ãªã³ãããã
ã¯ãã®ããã²ããã®å Žåããæ£ã«è·é»ããååå
ã®ç¬¬åçŽã¢ã³ã¢ããŠã åçªçŽ ãããã®ååå
ã§å¡©
ãäœãæãããªã³é
žæ®åºã®ïŒåã®æ°Žé
žåºã®ãã¡ã®
ïŒåãããšã¹ãã«åãã¢ããåãããªãçºã«åæ
ãå°é£ã§ãããšãããŠãããæ¬çºæè
ãã¯éæç
ç©¶ã®çµæãæç®æªèšèŒã®ãã¹ããªã«ã³ãªã³ã®ãžã¢
ããé¡ãå®äŸ¡ãªå·¥æ¥è¬åãã容æã«è£œé ãããã€
æ¬ååç©ãšã5â²âCMPãšã溶åªã®ååšäžããã
ã¯éååšäžã«ããŸãé
žãå¡©åºã®ååšäžãããã¯é
ååšäžã«åå¿ããããããšã«ãã€ãŠãåŸæ¥æ³ã®æ¬
ç¹ããªãããçæéã§ããã奜åçã«CDPâã³
ãªã³ãåŸãæ¹æ³ãèŠãåºããæ¬ç ç©¶ã宿ããã«
è³ã€ããããªãã¡æ¬çºæã«ããã°ãåèšäžè¬åŒ
ãããã¹ããªã«ã³ãªã³ãžã¢ãããŒãé¡ãš5â²â
CMPãšãåå¿ããããããšã«ãããCDPâã³ãª
ã³ã奜åçã§åŸãããã The present inventors have solved the drawbacks of such conventional methods, and have developed CDP-CDP, which is inexpensive, easy to react and operate, and is industrially advantageous.
As a result of intensive research aimed at establishing a method for producing choline, we discovered a new general formula that is easy to handle, inexpensive, and highly reactive. (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group.) Intermediate represented by:
Phosphorylcholine diamidates were discovered.
Conventionally, only monosubstituted amides of phosphorylcholine were known (for example, Japanese Patent Publication No. 45-27561, Japanese Patent Publication No. 47-38929, West German Patent Publication No. 2359245). Difficult to synthesize because the positively charged quaternary ammonium nitrogen in the molecule easily forms salts within the molecule, and only one of the two hydroxyl groups in the phosphoric acid residue is esterified or amidated. It was said to be. As a result of intensive research, the present inventors have found that phosphorylcholine diamides, which have not been described in any literature, can be easily produced using inexpensive industrial chemicals, and the present inventors can easily produce diamides of phosphorylcholine, which have not been described in literature, by combining the present compound and 5'-CMP in the presence or absence of a solvent. Furthermore, by conducting the reaction in the presence or absence of acids and bases, we discovered a method to eliminate the drawbacks of conventional methods and obtain CDP-choline in a short period of time and in good yields, leading to the completion of this research. Ivy. That is, according to the present invention, the phosphorylcholine diamidates of the general formula [] and 5'-
By reacting with CMP, CDP-choline can be obtained in good yield.
æ¬çºæã«ãããŠçšããããåºçºåæã®ïŒã€ã§ã
ããã¹ããªã«ã³ãªã³ãžã¢ãããŒãé¡ã¯åŸèšã§è©³çް
ã«ç€ºãéããäŸãã°Î²âã¯ãããšãã«ãã¹ããªã«
ãžã¢ãããŒãé¡ãããªã¡ãã«ã¢ãã³ãšåå¿ããã
ãããšã«ããã容æã«ãã€å¥œåçã§åŸãããšãåº
æ¥ãã As shown in detail later, phosphorylcholine diamidates, which are one of the starting materials used in the present invention, can be obtained easily and in good yield by, for example, reacting β-chloroethylphosphoryl diamidates with trimethylamine. You can get it.
æ¬çºæã«çšããããæº¶åªãšããŠã¯ãåå¿ãé»å®³
ããªã溶åªã§ããã°ãäœã§ãè¯ãããŸãç¹ã«ç¡æ°Ž
ã«ããå¿
èŠã¯ãªããæãŸããã¯ããžã¡ãã«ãã«ã
ã¢ããããžã¡ãã«ã¢ã»ãã¢ãããçãæå©ã§ãã
ããç¡æº¶åªäžã§ã宿œãããããåå¿æž©åºŠãšããŠ
ã¯ã宀枩ããæº¶åªã®æ²žç¹ãŸã§å®æœãããããæãŸ
ããã¯ã80ãã140âãæå©ã§ãããåå¿æéã¯30
åãã24æéãŸã§å®æœãããããæãŸããã¯ãïŒ
ãïŒæéãæå©ã§ããããã¹ããªã«ã³ãªã³ãžã¢ã
ããŒãé¡ã¯5â²âCMPã«å¯Ÿãçã¢ã«ä»¥äžäœ¿çšãã
ããšãã§ããã Any solvent may be used in the present invention as long as it does not inhibit the reaction, and there is no particular need to make it anhydrous. Preferably, dimethylformamide, dimethylacetamide, etc. are used, but it can also be carried out without a solvent. The reaction temperature is from room temperature to the boiling point of the solvent, preferably from 80° to 140°C. reaction time is 30
It is carried out from 1 minute to 24 hours, but preferably 1
~4 hours is advantageous. Phosphorylcholine diamidates can be used in an amount equal to or more than 5'-CMP.
åå¿ç³»ã«ååšããããé
žãšããŠã¯ãããªã¯ãã«
é
¢é
žçã®ææ©é
žã奜ãŸããããç¡«é
žãå¡©åæ°ŽçŽ ç
ã®ç¡æ©é
žã§ãè¯ããé
žã®äœ¿çšéã¯äœ¿çšãããã¹ã
ãªã«ã³ãªã³ãžã¢ãããŒãã®0.01ããïŒã¢ã«éçšåºŠ
ã奜ãŸããã The acid to be present in the reaction system is preferably an organic acid such as trichloroacetic acid, but may also be an inorganic acid such as sulfuric acid or hydrogen chloride. The amount of acid used is preferably about 0.01 to 1 mole of the phosphorylcholine diamidate used.
åå¿æ··åç©ããç®çç©ãåé¢ããã«ã¯ãåžžæ³ã«
åŸã€ãŠè¡ãã°è¯ããäŸãã°åå¿åŸã溶åªãçå»ã
ãããŸãã¯äžæŸãåŸæããŠé€ããããŸãã¯æº¶åªã
å ããŠæ²æŸ±ããããããŠãåŸãããæ®æž£ãæ°Žã«æº¶
è§£ããã¢ããªã³äº€ææš¹èã«ããç®çç©ãåžçãã
ããæ¬¡ãã§åžã®é
žæ°Žæº¶æ¶²ã§æº¶é¢ããããæº¶é¢ãã
CDPâã³ãªã³åºåãéããæ¿çž®ã也ç¥ããŠç®ç
ç©ã®CDPâã³ãªã³ãåŸãã The target product can be isolated from the reaction mixture by a conventional method. For example, after the reaction, the solvent is distilled off, the supernatant is decanted, or a solvent is added to precipitate, the resulting residue is dissolved in water, and the target product is adsorbed by an anion exchange resin. , followed by elution with dilute aqueous formic acid. eluted
The CDP-choline fraction is collected, concentrated and dried to obtain the target product, CDP-choline.
æ¬çºæã®ç¹åŸŽã¯éåžžã«æŽ»æ§åºŠã®é«ãåèšäžè¬åŒ
ããã®ååç©ãCDPâã³ãªã³ã®åæã«å©çšãã
ç¹ã«ãããå³ã¡äžè¬åŒããã®ååç©ã¯5â²â
CMPãšåå¿ãäžæŠäžèšäžè¬åŒããã
ïŒåŒäžïŒ®ïŒïŒ²ïŒ2ã¯ã¢ã«ããªãåºããŸãã¯äœçŽãžã¢
ã«ãã«ã¢ããåºã瀺ããïŒãåå¿äžéäœãšããŠäž
ããããåå¿æ¡ä»¶äžããã®ãã®ãåé¢ããããšãª
ãå æ°Žåè§£ãçµãŠã»ãšãã©å®éçã«ãã€é«çŽåºŠã«
CDPâã³ãªã³ãåŸãç¹ã«ãããæŽã«äžè¬åŒãã
ã®ååç©ãå©çšããããšã«ããé©åœãªæº¶åªïŒäŸã
ã°ãžã¡ãã«ã¢ã»ãã¢ããçïŒãéžã¶ããšã«ããã
5â²âCMPã®ããªïœâããã«ã¢ãã³å¡©ããªã«ãã¯
ããããšããŒã«æº¶åªäžãã¹ããªã«ã³ãªã³ã¢ãã¢ã
ããŒããšåå¿ãããå
¬ç¥äŸïŒç¹å
¬æ45â4747ïŒã®
åŠã5â²âCMPãäžæŠããªïœâããã«ã¢ãã³å¡©ãª
ã©ã®ææ©ã¢ãã³å¡©åããå¿
èŠããªã5â²âCMPèª
äœã§åå¿ãããããšãåºæ¥ãããŸããäžè¬åŒ
ãããš5â²âCMPã®åå¿ã®åå¿æéã¯å
ã«åŒäŸã®
ç¹å
¬æ45â4747ã®äŸç€ºã®å Žåã®100âã18æéã«
æ¯ã¹100âãïŒæéãšããããŠçããããã€åå¿
åŸã®æäœã溶åªãç¹ã«çå»ããå¿
èŠãªãäžæŸãåŸ
æããŠé€ãããšãåºæ¥ãçããããŠå·¥æ¥çã«åªã
ãæå©ãªæ¹æ³ã§ããã A feature of the present invention is that the compound of the general formula [], which has a very high activity, is utilized for the synthesis of CDP-choline. That is, the compound of general formula [] is 5'-
Once reacted with CMP, the following general formula [], (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group) is provided as a reaction intermediate, but under the reaction conditions, it is hydrolyzed without isolation, almost quantitatively and High purity
The point is to obtain CDP-choline. Furthermore, the general formula []
By selecting an appropriate solvent (e.g. dimethylacetamide, etc.),
5'-CMP is first converted into an organic amine salt such as tri-n-butylamine salt, as in a known example (Japanese Patent Publication No. 45-4747) in which tri-n-butylamine salt of 5'-CMP is reacted with phosphorylcholine monoamidate in an orthochlorophenol solvent. The reaction can be carried out with 5'-CMP itself without the need for further reaction. In addition, the reaction time for the reaction between the general formula [] and 5'-CMP is extremely short at 100°C for 3 hours, compared to 18 hours at 100°C in the case of the example cited in Japanese Patent Publication No. 45-4747. The subsequent operation is also an extremely industrially advantageous method in which the supernatant can be removed by decanting without the need to specifically distill off the solvent.
æ¬çºæã«ãããäžè¬åŒããã®ååç©ã§ããã
ã¹ããªã«ã³ãªã³ãžã¢ãããŒãé¡ã¯ä»¥äžã«è¿°ã¹ãäž
æ¹æ³ã§è£œé å¯èœã§ããåã
ã®ååç©ãåå¿æ¡ä»¶ç
ã«ããé©åãªæ¹æ³ãéžã¶ããšãåºæ¥ãããããã®
詳现ã«ã€ããŠä»¥äžé ã远ã€ãŠèª¬æããã Phosphorylcholine diamidates, which are compounds of the general formula [] in the present invention, can be produced by the three methods described below, and an appropriate method can be selected depending on the individual compound, reaction conditions, etc. Details of these methods are as follows: I will explain later.
è£œé æ³(1)
ïŒåŒäžãïŒïŒ²ïŒ2ã¯ã¢ã«ããªãåºããŸãã¯äœçŽãž
ã¢ã«ãã«ã¢ããåºã瀺ããïŒã§ç€ºãããåŠããã¯
ãããšãã«ãã¹ããªã«ãžã¢ãããŒãé¡ïŒäžè¬åŒ
ããïŒãçµç±ãããβâã¯ãããšãã«ãã¹ããªã«
ãžã¯ããªãïŒæç®äŸãJ.Amer.Chem.Soc.ã51ã
953ïŒ1929ïŒïŒã«ç¡æ°Žææ©æº¶åªäžã§ã¢ã«ããªã³ãŸã
ã¯äœçŽãžã¢ã«ãã«ã¢ãã³ãšåå¿ãããããšã«ãã
äžè¬åŒããã®ååç©ãåŸããã€ãã§äžè¬åŒ
ããã®ååç©ããäžè¬åŒãããžã®ååç©ã®å€
æã¯ãå°ç®¡äžããªã¡ãã«ã¢ãã³ãšåå¿ãããããš
ã«ããé«åçã§åŸããããåå¿æº¶åªãšããŠã¯ãå
å¿ãé»å®³ããªã溶åªãªãäœã§ãè¯ããäŸãã°ãã
ã³ãŒã³çã®è³éŠæçåæ°ŽçŽ é¡ãã¯ãããã«ã çã®
ããã²ã³åæ°ŽçŽ é¡ãããã©ãã€ãããã©ã³çã®ãš
ãŒãã«é¡ãã¢ã»ãã³çã®ã±ãã³é¡ãã¢ã»ããããª
ã«çã®ãããªã«é¡ããžã¡ãã«ãã«ã ã¢ããçã®ã¢
ããé¡ãæããããšãåºæ¥ãããæå©ã«ã¯ãã¢ã»
ããããªã«çã®ãããªã«é¡ãæãŸãããåå¿æž©åºŠ
ã¯å®€æž©ããæº¶åªã®æ²žç¹ã®éã§å®æœãããããæãŸ
ããã¯50ãã100âã®æž©åºŠã§å®æœããããåå¿æé
ã¯ãæ°æéããæ°æ¥éã§å®æœããããåå¿çæç©
ã¯ãåå¿æ¶²ãæ¿çž®ããããšã«ããçµæ¶ãŸãã¯ãªã€
ã«ãšããŠåŸããããManufacturing method (1) (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group.) via chloroethylphosphoryl diamidates (general formula []). β-chloroethylphosphoryl dichloride (Reference example, J.Amer.Chem.Soc., 51 ,
953 (1929)) with morpholine or lower dialkylamine in an anhydrous organic solvent to obtain a compound of general formula []. Then, the compound of general formula [] is converted into general formula [] by reacting it with trimethylamine in a sealed tube in a high yield. Any reaction solvent may be used as long as it does not inhibit the reaction, but examples include aromatic hydrocarbons such as benzene, hydrogen halides such as chloroform, ethers such as tetrahydrofuran, ketones such as acetone, and acetonitrile. Mention may be made of nitriles and amides such as dimethylformamide, but advantageously nitriles such as acetonitrile are preferred. The reaction temperature is between room temperature and the boiling point of the solvent, preferably between 50° and 100°C. Reaction times range from several hours to several days. The reaction product is obtained as crystals or oil by concentrating the reaction solution.
æ¬è£œé æ³ã¯äžè¬åŒããã®ååç©ã容æã«ãã€
å®äŸ¡ã«è£œé ããããç¹ã«ãããŠå·¥æ¥çã«ããããŠ
ããã This production method is industrially superior in that it allows the compound of general formula [] to be produced easily and at low cost.
è£œé æ³(2)
ïŒåŒäžãïŒïŒ²ïŒ2ã¯ã¢ã«ããªãåºãããã³äœçŽãž
ã¢ã«ãã«ã¢ããåºã瀺ããïŒ
ã³ãªã³ã¯ããªããšå
¬ç¥ã®ã¯ãããã¹ããªã«ãžã¢
ãããŒãïŒäžè¬åŒããïŒïŒæç®äŸãJ.Chem.
Soc.ã1958ã1963ïŒãšãå¡©åºååšäžåå¿ãããã
ãšã«ããäžè¬åŒããã§è¡šããããããã¹ããªã«
ã³ãªã³ãžã¢ãããŒãã¯ãã©ã€ããããåŸãã
ããåå¿æº¶åªãšããŠã¯ãæ¥µæ§ææ©æº¶åªãäŸãã°ã
ãžã¡ãã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·ãç
ãæããããšãåºæ¥ããå¡©åºãšããŠã¯ãæ°ŽçŽ åã
ããªãŠã çã®ç¡æ©å¡©åºãïŒã»ïŒã»âã«ããžã³ãã
ãªãžã³çã®ææ©å¡©åºãçšãããããåå¿æž©åºŠãšã
ãŠã¯ã宀枩ããæº¶åªã®æ²žç¹ã®éã§å®æœããããã
æãŸããã¯ã宀枩ãã150âã§å®æœããããåå¿
æéã¯ãæ°æéããæ°æ¥é宿œãããããæå©ã«
ã¯ãïŒæéååŸãæãŸãããåå¿çæç©ã¯ãæ²æŸ±
ç©ã濟åããæ¿Ÿæ¶²ãæžå§æ¿çž®ããããšã«ãããã
ã¹ããªã«ã³ãªã³ãžã¢ãããŒãã¯ãã©ã€ãã®çµæ¶ãŸ
ãã¯ãªã€ã«ãšããŠåŸããããManufacturing method (2) (In the formula, N(R) 2 represents a morpholino group and a lower dialkylamino group.) Choline chloride and the known chlorophosphoryl diamidate (general formula []) (Reference examples, J.Chem.
Soc., 1958 , 1963) in the presence of a base to obtain phosphorylcholine diamidate chloride [] represented by the general formula []. As the reaction solvent, polar organic solvents such as
Dimethylformamide, dimethylsulfoxide, etc. can be mentioned. As the base, an inorganic base such as sodium hydride, an organic base such as 2,6-lutidine, pyridine, etc. are used. The reaction temperature is between room temperature and the boiling point of the solvent,
Desirably, it is carried out at room temperature to 150°C. The reaction time ranges from several hours to several days, but is preferably around 8 hours. The reaction product is obtained as crystals or oil of phosphorylcholine diamidate chloride by filtering the precipitate and concentrating the filtrate under reduced pressure.
æ¬è£œé æ³ã¯äžè¬åŒããã®ååç©ãåçè¯ã補
é ããããç¹ã«ãããŠããããæ¹æ³ã§ããã This production method is an excellent method in that it allows the compound of general formula [] to be produced with good yield.
è£œé æ³(3)
ïŒåŒäžãïŒïŒ²ïŒ2ã¯ã¢ã«ããªãåºãããã³äœçŽãž
ã¢ã«ãã«ã¢ããåºã瀺ããïŒ
å
¬ç¥ã®ãã¹ããªã«ã³ãªã³ãžã¯ããªããŒãïŒæç®
äŸãCompt.Rend.ã257ã183ãïŒ1963ïŒãç¹å
¾47
â32970ïŒãšã¢ã«ããªã³ããŸãã¯äœçŽã¢ã«ãã«ã¢
ãã³ãåå¿ãããããšã«ãããäžè¬åŒããã§è¡š
ãããããã¹ããªã«ã³ãªã³ãžã¢ãããŒãã¯ãã©ã€
ããåŸããããåå¿æº¶åªãšããŠã¯ããžã¡ãã«ãã«
ã ã¢ããããžã¡ãã«ã¹ã«ããã·ããã¢ã»ããããª
ã«çã®æ¥µæ§æº¶åªãçšããããããç¡æº¶åªã§ã宿œ
ããããåå¿æž©åºŠãšããŠã¯ãæ°·ç¹äžããæº¶åªã®æ²ž
ç¹ã®éã§å®æœãããããæå©ã«ã¯ãâïŒâãã宀
æž©ã®éãæãŸãããåå¿æéãšããŠã¯ãæ°æéã
ãæ°æ¥é宿œãããããæå©ã«ã¯ãæ°æéãæãŸ
ãããåå¿çæç©ã¯ãæ²æŸ±ã濟åããæ¿Ÿæ¶²ãæžå§
æ¿çž®ããããšã«ããããã¹ããªã«ã³ãªã³ãžã¢ãã
ãŒãã¯ãã©ã€ãã®çµæ¶ãŸãã¯ããªã€ã«ãšããŠåŸã
ãããæ¬è£œé ã¯äžè¬åŒããã®ååç©ãçæéã«
ãã€å®¹æã«è£œé ããããç¹ã§ããããŠãããManufacturing method (3) (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group.) Known phosphorylcholine dichloridate (Literature example, Compt. Rend., 257 , 183, (1963), Japanese Patent Publication No. 47
-32970) with morpholine or lower alkylamine, phosphorylcholinediamidate chloride represented by the general formula [] is obtained. As the reaction solvent, polar solvents such as dimethylformamide, dimethylsulfoxide, acetonitrile, etc. are used, but the reaction can also be carried out without a solvent. The reaction temperature is carried out between below freezing and the boiling point of the solvent, preferably between -5°C and room temperature. The reaction time ranges from several hours to several days, and advantageously several hours. The reaction product is obtained as crystals or oil of phosphorylcholine diamidate chloride by filtering the precipitate and concentrating the filtrate under reduced pressure. This production is excellent in that it allows the compound of the general formula [] to be produced easily and in a short time.
以äžã«æ¬çºæã®å®æœäŸãäžã詳现ã«èª¬æãã
ãããããã¯æ¬çºæãéå®ãããã®ã§ã¯ãªãã Examples of the present invention will be described in detail below, but the present invention is not limited to these examples.
宿œäŸ ïŒ
ãã¹ããªã«ã³ãªã³ãžã¢ã«ããªããŒãã¯ãã©ã€ã
ïŒäžè¬åŒãããïŒïŒ²ïŒ2ïŒã¢ã«ããªãåºïŒ1.2ïœãš
5â²âCMP1ïœããžã¡ãã«ã¢ã»ãã¢ãã4.5mlã«æžæ¿
ã100âãïŒæéæ¹æäžåå¿ãããããåå¿åŸäž
æŸã®ãžã¡ãã«ã¢ã»ãã¢ãããåŸæããŠé€ããæ®æž£
ãæ°Žã«æº¶è§£ããã¢ã³ã¢ãã¢æ°Žã§PH9.5ã«èª¿æŽãã
ãã€ã¢ã€ãªã³SA11BïŒã®é
žåïŒ120mlã«åžçãã
ãã0.01ã0.03Mã®é
žã«ããæº¶é¢ãããCDPâã³
ãªã³ã®ãã©ã¯ã·ãšã³ãéããŠæ¿çž®ãã也ç¥ããã
ãšã«ããCDPâã³ãªã³1.44ïœãåŸãããªãæ¬åå
ç©ã¯ãããŒããŒã¯ãããã°ã©ãã€ãŒïŒãšã¿ããŒ
ã«ã0.5Mâé
¢é
žã¢ã³ã¢ã³ïŒïŒïŒïŒé«å§æ¿ŸçŽé»æ°
æ³³åïŒ0.2Mâãªã³é
žãããã¢ãŒPH7.4ã1500Vã
ïŒæéïŒãæ žç£æ°å
±é³Žåžåã¹ãã¯ãã«ïŒéæ°ŽäžïŒã
èµ€å€ç·åžåã¹ãã¯ãã«ïŒèåã«ãªãŠã ãã€ã¹ã¯ïŒã
玫å€ç·åžåã¹ãã¯ãã«ïŒPH11ãPH7.0ãPH1.5ïŒã§
æšåã®CDPâã³ãªã³ãšå®å
šã«äžèŽãããExample 1 1.2 g of phosphorylcholine dimorpholito chloride (general formula [ ], N(R) 2 = morpholino group)
1 g of 5'-CMP was suspended in 4.5 ml of dimethylacetamide and reacted at 100°C for 3 hours with stirring. After the reaction, the supernatant dimethylacetamide was decanted, the residue was dissolved in water, and the pH was adjusted to 9.5 with aqueous ammonia.
Adsorb to 120 ml of Diaion SA11B (formic acid type) and elute with 0.01-0.03M formic acid. CDP-choline fractions were collected, concentrated, and dried to obtain 1.44 g of CDP-choline. This compound was analyzed by paper chromatography (ethanol, 0.5M ammonium acetate 5:2), high pressure filter paper electrophoresis (0.2M phosphate buffer PH7.4, 1500V,
2 hours), nuclear magnetic resonance absorption spectrum (in heavy water),
Infrared absorption spectrum (potassium bromide disk),
The ultraviolet absorption spectrum (PH11, PH7.0, PH1.5) completely matched that of standard CDP-choline.
宿œäŸ ïŒ
ãã¹ããªã«ã³ãªã³ãžã¢ã«ããªããŒãã¯ãã©ã€ã
1.2ïœãš5â²âCMP1.0ïœãæ··åãã100âã§æ¹æäž
ïŒæéå ç±åå¿ãããããåå¿åŸåå¿æ··åç©ãæ°Ž
ã«æº¶è§£ãã宿œäŸïŒãšåæ§ã«ã€ãªã³äº€ææš¹èã«ã
ã粟補åŠçãè¡ããCDPâã³ãªã³åç»ãéããŠ
æ¿çž®ãã也ç¥ããããšã«ãããCDPâã³ãªã³ã®
çŽå1.28ïœãåŸããããããŠåŸãããCDPâã³ãª
ã³ã¯å®æœäŸïŒãšåæ§ã«ãæšåã®CDPâã³ãªã³ãš
æ¯èŒåå®ãããšãããå®å
šã«äžèŽãããExample 2 Phosphorylcholine dimolholitochloride
1.2 g and 1.0 g of 5'-CMP were mixed and reacted by heating at 100°C for 4 hours with stirring. After the reaction, the reaction mixture was dissolved in water, purified using an ion exchange resin in the same manner as in Example 1, and the CDP-choline fraction was collected, concentrated, and dried to obtain 1.28 g of pure CDP-choline. Obtained. The thus obtained CDP-choline was compared and identified with the standard CDP-choline in the same manner as in Example 1, and it was found to be completely identical.
宿œäŸ ïŒ
ãã¹ããªã«ã³ãªã³ãžã¢ã«ããªããŒãã¯ãã©ã€ã
1.2ïœãš5â²âCMP1.0ïœããžã¡ãã«ã¢ã»ãã¢ãã4.5
mlã«æžæ¿ãã100âãïŒæéæ¹æäžåå¿ããããã
åå¿åŸäžæŸã®ãžã¡ãã«ã¢ã»ãã¢ãããåŸæããŠé€
ããæ®æž£ãæ°Žã«æº¶è§£ãã宿œäŸïŒãšåæ§ã«ã€ãªã³
äº€ææš¹èã«ãã粟補åŠçãè¡ããCDPâã³ãªã³
åç»ãéããŠæ¿çž®ãã也ç¥ããããšã«ããã
CDPâã³ãªã³ã®çŽå1.38ïœãåŸããããããŠåŸã
ããCDPâã³ãªã³ã¯å®æœäŸïŒãšåæ§ã«ãæšåã®
CDPâã³ãªã³ãšæ¯èŒåå®ãããšãããå®å
šã«äž
èŽãããExample 3 Phosphorylcholine dimorpholitochloride
1.2g and 1.0g of 5â²-CMP with 4.5g of dimethylacetamide
ml and reacted at 100°C for 3 hours with stirring.
After the reaction, the supernatant dimethylacetamide was decanted, the residue was dissolved in water, and purified using an ion exchange resin in the same manner as in Example 1. The CDP-choline fraction was collected, concentrated, and dried. ,
1.38 g of pure CDP-choline was obtained. The thus obtained CDP-choline was prepared in the same way as in Example 1.
When compared and identified with CDP-choline, they were completely identical.
宿œäŸ ïŒ
ãã¹ããªã«ã³ãªã³âã»Nâ²âãžãšãã«ãžã¢ã
ããŒãã¯ãã©ã€ãïŒäžè¬åŒãããïŒãšãã«ïŒ
1.98ïœãš5â²âCMP0.96ïœããžã¡ãã«ã¢ã»ãã¢ãã
ïŒmlã«å ãã120âãïŒæéæ¹æäžåå¿ããããã
åå¿åŸã宿œäŸïŒãšåæ§ã«åŠçããŠãCDPâã³
ãªã³0.88ïœãåŸããããããŠåŸãããCDPâã³ãª
ã³ã¯å®æœäŸïŒãšåæ§ã«ãæšåã®CDPâã³ãªã³ãš
æ¯èŒåå®ãããšãããå®å
šã«äžèŽãããExample 4 Phosphorylcholine-Nã»N'-diethyldiamidate chloride (general formula [], R=ethyl)
1.98 g and 0.96 g of 5'-CMP were added to 3 ml of dimethylacetamide and reacted at 120°C for 3 hours with stirring.
After the reaction, the same treatment as in Example 1 was carried out to obtain 0.88 g of CDP-choline. The thus obtained CDP-choline was compared and identified with the standard CDP-choline in the same manner as in Example 1, and it was found to be completely identical.
宿œäŸ ïŒ
βâã¯ãããšãã«ãã¹ããªã«ãžã¯ããªã10ïœã«
ãã³ãŒã³20mlãå ããæ°·å·äžæ¹æããªããã¢ã«ã
ãªã³17.7ïœããã³ãŒã³60mlã«æº¶ãããæº¶æ¶²ãåŸã
ã«æ»Žäžãããæ»ŽäžçµäºåŸå®€æž©ã§ïŒæéæ¹æããæ
åºããã¢ã«ããªã³ã®å¡©é
žå¡©ã濟åãããæ¿Ÿæ¶²ãæ¿
瞮也åºã10â以äžã§æŸçœ®ãããšçµæ¶ãæåºããã
ãšãŒãã«ã§çµæ¶ãæŽæ»ã也ç¥ãããšãèç¹53ãã
58âã®Î²âã¯ãããšãã«ãã¹ããªã«ãžã¢ã«ããªã
ãŒãïŒäžè¬åŒãããïŒïŒ²ïŒ2ïŒã¢ã«ããªãåºïŒã®
çœè²çµæ¶13.1ïœãåŸããããExample 5 20 ml of benzene is added to 10 g of β-chloroethylphosphoryl dichloride, and a solution of 17.7 g of morpholine dissolved in 60 ml of benzene is gradually added dropwise while stirring under ice cooling. After the addition was completed, the mixture was stirred at room temperature for 1 hour, and the precipitated morpholine hydrochloride was collected by filtration. If the filtrate is concentrated to dryness and left at 10°C or lower, crystals will precipitate.
When the crystals are washed with ether and dried, the melting point is 53° ~
13.1 g of white crystals of β-chloroethylphosphoryl dimorpholinate (general formula [], N(R) 2 =morpholino group) at 58° C. were obtained.
å
çŽ åæïŒC10H20ClN2O4PãšããŠïŒ
çè«å€ ïŒ40.21ïŒ
ãïŒ6.75ïŒ
ãïŒ9.37ïŒ
åæå€ ïŒ40.14ïŒ
ãïŒ6.83ïŒ
ãïŒ9.38ïŒ
次ã«ãã®Î²âã¯ãããšãã«ãã¹ããªã«ãžã¢ã«ã
ãªããŒãïŒïœã«ãããªã¡ãã«ã¢ãã³ã®30ïŒ
ã¢ã»ã
ãããªã«æº¶æ¶²20ïœãå ããå°ç®¡äž70âã§48æéå
å¿ããããåå¿åŸæåºç©ã濟åããæ¿Ÿæ¶²ãæ¿çž®
ããå°éã®ãžãªããµã³ãå ã10â以äžã§æŸçœ®ãã
ãšçµæ¶åããèç¹64ãã70âã®ãã¹ããªã«ã³ãªã³
ãžã¢ã«ããªããŒãã¯ãã©ã€ãïŒäžè¬åŒãã
ïŒïŒ²ïŒ2ïŒã¢ã«ããªãåºïŒã®çœè²çµæ¶5.4ïœãåŸãã
ããElemental analysis (as C 10 H 20 ClN 2 O 4 P) Theoretical value C: 40.21%, H: 6.75%, N: 9.37% Analytical value C: 40.14%, H: 6.83%, N: 9.38% Next, this β - Add 20 g of a 30% acetonitrile solution of trimethylamine to 5 g of chloroethylphosphoryl dimorpholidate and react in a sealed tube at 70° C. for 48 hours. After the reaction, the precipitate is collected by filtration, the filtrate is concentrated, a small amount of dioxane is added, and when it is left to stand at below 10°C, it crystallizes to form phosphorylcholine dimorpholidite chloride (general formula []N
5.4 g of white crystals of (R) 2 =morpholino group) were obtained.
å
çŽ åæïŒC13H29ClN3O4Pã»H2OãšããŠïŒ
çè«å€ïŒ£ïŒ41.73ïŒ
ãïŒ8.36ïŒ
ãïŒ11.22ïŒ
åæå€ïŒ£ïŒ41.85ïŒ
ãïŒ8.41ïŒ
ãïŒ11.39ïŒ
åŸããããã¹ããªã«ã³ãªã³ãžã¢ã«ããªããŒãã¯
ãã©ã€ããçšã宿œäŸïŒãïŒã®ãšãã宿œãåã
ãã·ããžã³ãžãªã³é
žã³ãªã³ãåŸããElemental analysis (as C 13 H 29 ClN 3 O 4 Pã»H 2 O) Theoretical value C: 41.73%, H: 8.36%, N: 11.22% Analytical value C: 41.85%, H: 8.41%, N: 11.39% Using the obtained phosphorylcholine dimorpholithochloride, the same procedure as in Examples 1 to 3 was carried out to obtain choline cytidine diphosphate.
宿œäŸ ïŒ
βâã¯ãããšãã«ãã¹ãããžã¯ãã©ã€ã10ïœã«
ãã³ãŒã³20mlãå ããæ°·å·äžæ¹æããªããããžãš
ãã«ã¢ãã³15.6ïœããã³ãŒã³60mlã«æº¶ãããæº¶æ¶²
ãæ»Žäžãããæ»ŽäžçµäºåŸå®€æž©ã§ïŒæéæ¹æããæ
åºããæ²æŸ±ãæ¿Ÿåããæ¿Ÿæ¶²ãæ¿ç·ãããæ®æž£ãæž
å§èžçããããšã«ãããæ²žç¹108âïŒïŒmmHgïŒã®
ç¡è²ãªã€ã«ç¶ã®Î²âã¯ãããšãã«ãã¹ããâã»
Nâ²âãžãšãã«ãžã¢ãããŒãïŒäžè¬åŒããïŒ
ãšãã«ïŒ9.6ïœãåŸããããExample 6 20 ml of benzene is added to 10 g of β-chloroethylphosphorodichloride, and a solution of 15.6 g of diethylamine dissolved in 60 ml of benzene is added dropwise while stirring under ice cooling. After the addition was completed, the mixture was stirred at room temperature for 1 hour, the precipitate was collected by filtration, and the filtrate was concentrated. By distilling the residue under reduced pressure, β-chloroethylphosphoro-N.
N'-diethyldiamidate (general formula []R=
ethyl) was obtained.
次ã«ãã®Î²âã¯ãããšãã«ãã¹ããâã»
Nâ²âãžãšãã«ãžã¢ãããŒãïŒïœã«ãããªã¡ãã«
ã¢ãã³ã®30ïŒ
ã¢ã»ããããªã«æº¶æ¶²20ïœãå ããå°
管äž70âã«ãŠ48æéåå¿ãããããåå¿åŸãåå¿
æ¶²ãæ¿çž®ãããžãªããµã³ãå ããäžæº¶ç©ã濟åã
ããæ¿Ÿæ¶²ãæ¿çž®ä¹Ÿåºãããšããã¹ããªã«ã³ãªã³â
ã»Nâ²âãžãšãã«ãžã¢ãããŒãã¯ãã©ã€ãïŒäž
è¬åŒããïŒãšãã«ïŒã3.65ïœåŸãããããã®
ãã®ã¯ããŒããŒã¯ãããã°ã©ãã€ãŒã§ã¢ãã¹ãã
ãã§ããïŒãšã¿ããŒã«ïŒ0.5Mâé
¢é
žã¢ã³ã¢ã³ã
10ïŒïŒãHI詊è¬ã§æ€åºãïŒãã¬ã¹ãã·ãªã«ã²ã«è
å±€ã¯ãããã°ã©ãã€ãŒã§ãã¢ãã¹ãããã§ãã€ã
ïŒã¯ãããã«ã ïŒã¡ã¿ããŒã«ãïŒïŒïŒãHI詊è¬ã
ãšãŠçŽ ã§æ€åºãïŒãæ žç£æ°å
±é³Žåžåã¹ãã¯ãã«ã
ÎŽ1.17ïŒ12HãïœãïŒïŒHzïŒãÎŽ3.1ïŒ8HãïœãïŒã
ÎŽ3.27ïŒ9HãïœïŒãÎŽ3.72ïŒ2HãïœïŒãÎŽ4.35ïŒ2Hã
ïœïŒããæº¶åªã¡ã¿ããŒã«âd4ãå
éšæšæºTMSã
Varian â60ã
åŸããããã¹ããªã«ã³ãªã³âã»Nâ²âãžãšã
ã«ãžã¢ãããŒãã¯ãã©ã€ããçšã宿œäŸïŒã®ãšã
ã宿œãåããã·ããžã³ãžãªã³é
žã³ãªã³ãåŸãã Next, this β-chloroethylphosphoro-Nã»
20 g of a 30% acetonitrile solution of trimethylamine was added to 5 g of N'-diethyldiamidate, and the mixture was allowed to react in a sealed tube at 70° C. for 48 hours. After the reaction, the reaction solution is concentrated, dioxane is added, and insoluble matter is filtered off. When the filtrate is concentrated to dryness, phosphorylcholine-
3.65 g of N.N'-diethyldiamidate chloride (general formula []R=ethyl) was obtained. This is a paper chromatography monospot (ethanol: 0.5M - ammonium acetate,
10:1, detected with HI reagent), gas, and silica gel thin layer chromatography (chloroform:methanol, 1:2, HI reagent,
Detected with iodine). nuclear magnetic resonance absorption spectrum,
ÎŽ1.17 (12H, t, J=7Hz), ÎŽ3.1 (8H, m,),
ÎŽ3.27 (9H, s), ÎŽ3.72 (2H, m), ÎŽ4.35 (2H,
m), [solvent methanol- d4 , internal standard TMS,
Varian T-60] Using the obtained phosphorylcholine-N·N'-diethyldiamidate chloride, the same procedure as in Example 4 was carried out to obtain choline cytidine diphosphate.
宿œäŸ ïŒ
ã³ãªã³ã¯ããªã1.4ïœãšã¯ãããã¹ããªã«ãžã¢
ã«ããªããŒã2.55ïœããžã¡ãã«ã¹ã«ããã·ãïŒml
ã«æ··åããæ¹æããªããæ°ŽçŽ åãããªãŠã 0.24ïœ
ãå ãã宀枩ã§ïŒæéæ¹æäžåå¿ããããåå¿åŸ
æåºããå°éã®æ²æŸ±ã濟åããæ¿Ÿæ¶²ãæžå§äžæ¿çž®
也åºãããæ®æž£ã«å°éã®ã¢ã»ããããªã«ãå ãã
濟éããæ¿Ÿæ¶²ãæ¿çž®ãã10â以äžã§æŸçœ®ãããšã
çœè²çµæ¶ã®ãã¹ããªã«ã³ãªã³ãžã¢ã«ããªããŒãã¯
ãã©ã€ãïŒäžè¬åŒããïŒïŒ²ïŒ2ïŒã¢ã«ããªãåºïŒ
ã2.05ïœåŸãããããã®ãã®ã¯å®æœäŸïŒã§åŸãã
ãçµæ¶ãšèç¹ãããŒããŒã¯ãããã°ã©ãã€ãŒïŒãš
ã¿ããŒã«ïŒ0.5Mâé
¢é
žã¢ã³ã¢ã³ã10ïŒïŒãHI詊
è¬ã§æ€åºïŒãã§å®å
šã«äžèŽãããExample 7 1.4 g of choline chloride and 2.55 g of chlorophosphoryl dimorpholidate were mixed with 5 ml of dimethyl sulfoxide.
0.24 g of sodium hydride while stirring.
was added and reacted at room temperature for 8 hours with stirring. After the reaction, a small amount of precipitate is collected by filtration, and the filtrate is concentrated to dryness under reduced pressure. Add a small amount of acetonitrile to the residue,
Filter, concentrate the filtrate, and leave it at below 10°C.
White crystalline phosphorylcholine dimorpholitochloride (general formula []N(R) 2 = morpholino group)
2.05g of was obtained. This product completely matched the crystals obtained in Example 5 in melting point and paper chromatography (ethanol:0.5M ammonium acetate, 10:1, detected with HI reagent).
åŸããããã¹ããªã«ã³ãªã³ãžã¢ã«ããªããŒãã¯
ãã©ã€ããçšã宿œäŸïŒãïŒã®ãšãã宿œãåã
ãã·ããžã³ãžãªã³é
žã³ãªã³ãåŸãã Using the obtained phosphorylcholine dimorpholithochloride, the same procedure as in Examples 1 to 3 was carried out to obtain choline cytidine diphosphate.
宿œäŸ ïŒ
ãã¹ããªã«ã³ãªã³ãžã¯ããªããŒãïŒïœãã¢ã»ã
ãããªã«ïŒmlã«å ããæ¹æäžãå·åŽããªããã¢ã«
ããªã³1.36ïœã滎äžãããæ»ŽäžçµäºåŸå®€æž©ã§ïŒæ
éæ¹æãããã³ãŒã³10mlãå ããå®€æž©ã§æŽã«30å
éæ¹æããæåºããçœè²çµæ¶ã濟åãããæ¿Ÿæ¶²ã
æ¿çž®ä¹Ÿåºããæ®æž£ã«å°éã®ã¢ã»ããããªã«ãå ã
濟éããæ¿Ÿæ¶²ã10âäžäžã§æŸçœ®ãããšãçœè²çµæ¶
ã®ãã¹ããªã«ã³ãªã³ãžã¢ã«ããªããŒãã¯ãã©ã€ã
0.56ïœãåŸãããããã®çµæ¶ã¯å®æœäŸïŒã§åŸãã
ãçµæ¶ãšèç¹ãããŒããŒã¯ãããã°ã©ãã€ãŒãæ ž
ç£æ°å
±é³Žåžåã¹ãã¯ãã«ã§å®å
šã«äžèŽãããExample 8 1 g of phosphorylcholine dichloridate is added to 4 ml of acetonitrile, and 1.36 g of morpholine is added dropwise while stirring and cooling. After the addition was completed, the mixture was stirred at room temperature for 3 hours, 10 ml of benzene was added, and the mixture was further stirred at room temperature for 30 minutes, and the precipitated white crystals were collected by filtration. The filtrate is concentrated to dryness, a small amount of acetonitrile is added to the residue, it is filtered, and the filtrate is left at 10°C or lower to produce white crystals of phosphorylcholine dimorpholitochloride.
0.56g was obtained. This crystal completely matched the crystal obtained in Example 5 in melting point, paper chromatography, and nuclear magnetic resonance absorption spectrum.
åŸããããã¹ããªã«ã³ãªã³ãžã¢ã«ããªããŒãã¯
ãã©ã€ããçšã宿œäŸïŒãïŒã®ãšãã宿œãåã
ãã·ããžã³ãžãªã³é
žã³ãªã³ãåŸãã Using the obtained phosphorylcholine dimorpholithochloride, the same procedure as in Examples 1 to 3 was carried out to obtain choline cytidine diphosphate.
Claims (1)
ã«ãã«ã¢ããåºã瀺ããïŒã§è¡šãããããã¹ããª
ã«ã³ãªã³ãžã¢ãããŒãé¡ãšã·ããžã³â5â²âã¢ããª
ã³é žãåå¿ããããããšãç¹åŸŽãšããã·ããžã³ãž
ãªã³é žã³ãªã³ã®è£œé æ¹æ³ã ïŒ äžè¬åŒãã ïŒåŒäžïŒ®ïŒïŒ²ïŒ2ã¯ã¢ã«ããªãåºããŸãã¯äœçŽãžã¢
ã«ãã«ã¢ããåºã瀺ããïŒã§è¡šããããβâã¯ã
ããšãã«ãã¹ããªã«ãžã¢ãããŒããããªã¡ãã«ã¢
ãã³ãšåå¿ããäžè¬åŒããã§è¡šãããããã¹ã
ãªã«ã³ãªã³ãžã¢ãããŒãé¡ãšããã€ãã§ã·ããžã³
â5â²âã¢ããªã³é žãšåå¿ããããããšãç¹åŸŽãšã
ãã·ããžã³ãžãªã³é žã³ãªã³ã®è£œé æ¹æ³ã ïŒ äžè¬åŒãã ïŒåŒäžïŒ®ïŒïŒ²ïŒ2ã¯ã¢ã«ããªãåºããŸãã¯äœçŽãžã¢
ã«ãã«ã¢ããåºã瀺ããïŒã§è¡šããããã¯ããã
ã¹ããªã«ãžã¢ãããŒãé¡ãšã³ãªã³ã¯ããªããåå¿
ããäžè¬åŒããã§è¡šãããããã¹ããªã«ã³ãªã³
ãžã¢ãããŒãé¡ãšããã€ãã§ã·ããžã³â5â²âã¢ã
ãªã³é žãšåå¿ããããããšãç¹åŸŽãšããã·ããžã³
ãžãªã³é žã³ãªã³ã®è£œé æ¹æ³ã ïŒ ãã¹ããªã«ã³ãªã³ãžã¯ããªããŒããšã¢ã«ããª
ã³ãŸãã¯äœçŽãžã¢ã«ãã«ã¢ãã³ãåå¿ããäžè¬åŒ
ããã§è¡šãããããã¹ããªã«ã³ãªã³ãžã¢ãããŒ
ãé¡ãšããã€ãã§ã·ããžã³â5â²âã¢ããªã³é žãšå
å¿ããããããšãç¹åŸŽãšããã·ããžã³ãžãªã³é žã³
ãªã³ã®è£œé æ¹æ³ã[Claims] 1. General formula [] (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group.) Production of choline cytidine diphosphate, which is characterized by reacting a phosphorylcholine diamidate represented by the formula with cytidine-5'-monophosphoric acid. Method. 2 General formula [] (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group) is reacted with trimethylamine to obtain phosphorylcholine diamidates represented by the general formula []. , and then reacting with cytidine-5'-monophosphoric acid. 3 General formula [] (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group) is reacted with choline chloride to obtain phosphorylcholine diamidates represented by the general formula [ ], A method for producing choline cytidine diphosphate, which comprises then reacting it with cytidine-5'-monophosphoric acid. 4. A method for producing choline cytidine diphosphate, which comprises reacting phosphorylcholine dichloridate with morpholine or lower dialkylamine to obtain phosphorylcholine diamidates represented by the general formula [], and then reacting with cytidine-5'-monophosphoric acid. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7454979A JPS55167298A (en) | 1979-06-15 | 1979-06-15 | Preparation of cytidine diphosphate choline |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7454979A JPS55167298A (en) | 1979-06-15 | 1979-06-15 | Preparation of cytidine diphosphate choline |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55167298A JPS55167298A (en) | 1980-12-26 |
| JPS636079B2 true JPS636079B2 (en) | 1988-02-08 |
Family
ID=13550434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7454979A Granted JPS55167298A (en) | 1979-06-15 | 1979-06-15 | Preparation of cytidine diphosphate choline |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55167298A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0282215U (en) * | 1988-12-16 | 1990-06-26 |
-
1979
- 1979-06-15 JP JP7454979A patent/JPS55167298A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0282215U (en) * | 1988-12-16 | 1990-06-26 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55167298A (en) | 1980-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0521923B1 (en) | Process for producing nucleosides, and analogs therof | |
| US4567254A (en) | Method for preparing N6,8-disubstituted 3',5'-cyclic adenosine monophosphate and salt thereof | |
| CA2268586A1 (en) | Process for producing n-glycyltyrosine and its crystal structure | |
| US4751293A (en) | Process for preparation of N6 -substituted 3',5'-cyclic adenosine monophosphate and salt thereof | |
| JPS636079B2 (en) | ||
| JPS5936914B2 (en) | Cephalosporin analogs | |
| BG62287B1 (en) | Method and intermediate product for oxytetracycline purification | |
| US4371472A (en) | Process for preparing cysteamine-S-substituted compounds and derivatives thereof | |
| JPS6331475B2 (en) | ||
| JPS629598B2 (en) | ||
| CA1297878C (en) | Process for the obtention of the ethyl ester of the apovincaminic acid | |
| US5215973A (en) | Optically active and racemic hydrated diacetylesters of α-glycero-phosphoryl-choline | |
| CN86108424A (en) | The synthetic method of nizatidine | |
| JPH10287657A (en) | Production of radiosensitizer | |
| EP0293244A2 (en) | N epsilon-trifluoroacetyl-L-lysyl-L-proline.D-1O-camphorsulfonic acid salt and process for producing the same | |
| JPH03135995A (en) | Separation and purification of 8-alkoxyadenosine-3',5'-cyclic phosphate | |
| JPS601199A (en) | Preparation of cytidine-5'-diphosphate choline | |
| EP0690848B1 (en) | Piperazinylpyridinyl water clathrates | |
| US5164500A (en) | Oxetanocin G | |
| KR0164947B1 (en) | New preparation of 7-amino-3-methoxymethyl-3-cepem-4-carboxylic acid | |
| CN121591669A (en) | A method for preparing a sinoamine intermediate | |
| KR930007816B1 (en) | New Preparation Method of Cefem Compound | |
| JPS633877B2 (en) | ||
| SU802285A1 (en) | Method of preparing 1-beta-d-arabinofuranosyl-5-fluorocytosine | |
| JPH07116213B2 (en) | Novel N-6,2'-O-disubstituted-adenosine-3 ', 5'-cyclic phosphate and process for producing the same |